Linderalactone
Selleck Chemicals
SKU:E0011-5MG
Couldn't load pickup availability
Linderalactone is a compound reported to inhibit human lung cancer growth by modulating the expression of apoptosis-related proteins (Bax and Bcl-2) with an IC50 of 15 µM in A-549 cells.
Product background
This compound induces G2/M cell cycle arrest and could also suppress the JAK/STAT signaling pathway. It can be isolated from Radix linderae. These details define the compound context without adding unlisted selectivity or validation claims, helping researchers select the molecule for pathway comparison, screening panels or follow-up experiments.
Laboratory context
It can support laboratory workflows involving protein-binding, cell-uptake and SPR assays in oncology research, provided the experimental design matches the reported activity and assay context and includes appropriate controls for interpretation.
- Research Area:
- Oncology
- Application:
- Protein Binding • Cell Uptake Studies • SPR
- CAS No.:
- 728-61-0
- Molecular Weight:
- 244.29
- Formula:
- C₁₅H₁₆O₃
- SMILES:
- CC/1=C\CCC2=CC(OC2=O)C3=C(C1)OC=C3C
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.